Organon & Co. [NYSE: OGN] plunged by -$0.32 during the normal trading session on while it closed the day at $18.26.
Organon & Co. stock has also loss -4.75% of its value over the past 7 days. However, OGN stock has declined by -9.20% in the 3 months of the year. Over the past six months meanwhile, it has gained 2.18% and gained 26.63% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for OGN stock reached $4.70 billion, with 257.47 million shares outstanding and 256.91 million shares in the current float. Compared to the average trading volume of 1.80M shares, OGN reached a trading volume of 2203517 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Organon & Co. [OGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OGN shares is $22.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OGN stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Organon & Co. shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on September 06, 2024. While these analysts kept the previous recommendation, Goldman dropped their target price from $33 to $16. The new note on the price target was released on November 03, 2023, representing the official price target for Organon & Co. stock. Previously, the target price had yet another raise to $28, while Barclays analysts kept a Overweight rating on OGN stock.
The Average True Range (ATR) for Organon & Co. is set at 0.56, with the Price to Sales ratio for OGN stock in the period of the last 12 months amounting to 0.74. The Price to Book ratio for the last quarter was 32.65, with the Price to Cash per share for the same quarter was set at 2.73. Price to Free Cash Flow for OGN in the course of the last twelve months was 5.51 with Quick ratio for the last quarter at 1.17.
OGN stock trade performance evaluation
Organon & Co. [OGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.75. With this latest performance, OGN shares dropped by -17.82% in over the last four-week period, additionally plugging by 2.18% over the last 6 months – not to mention a rise of 12.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OGN stock in for the last two-week period is set at 29.59, with the RSI for the last a single of trading hit 22.09, and the three-weeks RSI is set at 34.78 for Organon & Co. [OGN]. The present Moving Average for the last 50 days of trading for this stock 20.60, while it was recorded at 18.80 for the last single week of trading, and 19.03 for the last 200 days.
Organon & Co. [OGN]: An insightful look at the core fundamentals
Organon & Co.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.17 and a Current Ratio set at 1.64.
Earnings per share (EPS) analysis for Organon & Co. [OGN] stock
With the latest financial reports released by the company, Organon & Co. posted 0.87/share EPS, while the average EPS was predicted by analysts to be reported at 1.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.19. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Organon & Co. go to 3.10%.
Organon & Co. [OGN]: Institutional Ownership
There are presently around $79.86%, or 79.99%% of OGN stock, in the hands of institutional investors. The top three institutional holders of OGN stocks are: BLACKROCK INC. with ownership of 32.58 million shares, which is approximately 12.7414%. VANGUARD GROUP INC, holding 30.21 million shares of the stock with an approximate value of $$625.41 million in OGN stocks shares; and VANGUARD GROUP INC, currently with $$208.88 million in OGN stock with ownership which is approximately 3.9465%.
